1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Undifferentiated Carcinoma: new trials by email Literature Review of Undifferentiated Carcinoma trials Research Report on Undifferentiated Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Abraxane, Erbitux, Carboplatin - Squamous Cell Carcinoma of the Head and Neck, Basaloid Squamous Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Dana-Farber Cancer Institute | 29 | 2007-11-01 | 2017-11-13 |
Carcinoma (1) · Carcinoma, Adenosquamous (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Glandular and Epithelial (1)
Albumin-Bound Paclitaxel (1) · Carboplatin (1) · Cetuximab (1) · Paclitaxel (1) · Radiotherapy, Intensity-Modulated (1)
Dana-Farber Cancer Institute (1)